John C. Riches

3.1k total citations · 2 hit papers
44 papers, 1.9k citations indexed

About

John C. Riches is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, John C. Riches has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 18 papers in Oncology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in John C. Riches's work include Chronic Lymphocytic Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (16 papers) and CAR-T cell therapy research (10 papers). John C. Riches is often cited by papers focused on Chronic Lymphocytic Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (16 papers) and CAR-T cell therapy research (10 papers). John C. Riches collaborates with scholars based in United Kingdom, United States and Canada. John C. Riches's co-authors include John G. Gribben, Alan G. Ramsay, Rewas Fatah, Fabienne McClanahan, Andrew Clear, Sameena Iqbal, Jeffrey K. Davies, Samir Agrawal, Jennifer Watt and John F. Marshall and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Gastroenterology.

In The Last Decade

John C. Riches

40 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

2013 441 citations Andrew Clear, John C. Riches et al. profile →
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

2020 330 citations Abi Vijenthira, Inna Y. Gong et al. Blood profile →

Peers

Countries citing papers authored by John C. Riches

Since Specialization

Citations

This map shows the geographic impact of John C. Riches's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Riches with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Riches more than expected).

Fields of papers citing papers by John C. Riches

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Riches. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Riches. The network helps show where John C. Riches may publish in the future.

Co-authorship network of co-authors of John C. Riches

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Riches. A scholar is included among the top collaborators of John C. Riches based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Riches. John C. Riches is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia 2025 ·British Journal of Haematology ·Renata Walewska, Toby A. Eyre, Adrian Bloor, (unknown), Sunil Iyengar, (unknown), Helen Marr, Nicolás Martínez‐Calle, Alison M. McCaig, (unknown), Talha Munir, Helen Parry, Nilima Parry‐Jones, Andrew R. Pettitt, John C. Riches, Ingo Ringshausen, Anna Schuh, Piers Patten	0
2	The impact of real-time feedback on ventilation quality during out-of-hospital cardiac arrest: A before-and-after study 2024 ·Resuscitation ·Ian R. Drennan, (unknown), (unknown), Andrew Lee, John C. Riches, (unknown), (unknown), Sheldon Cheskes	8
3	Taking the Next Step in Double Refractory Disease: Current and Future Treatment Strategies for Chronic Lymphocytic Leukemia 2024 ·OncoTargets and Therapy ·Manabu Hayama, John C. Riches	1
4	Robust Bruton’s tyrosine kinase (BTK) degradation with NX‐5948, an oral BTK degrader, in a first‐in‐human phase 1a trial in relapsed/refractory B cell malignancies 2023 ·Hematological Oncology ·Kim Linton, Francesco Forconi, David Lewis, John C. Riches, Dima El‐Sharkawi, Mary Gleeson, (unknown), (unknown), (unknown), Ganesh Cherala, Graham P. Collins	4
5	Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers 2023 ·OncoTargets and Therapy ·Annalisa D’Avola, Katarína Kľučková, Andrew J. Finch, John C. Riches	7
6	The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives 2023 ·Cancers ·Toby A. Eyre, John C. Riches	16
7	Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era? 2023 ·Frontiers in Oncology ·Jennifer Edelmann, Jitka Malčíková, John C. Riches	1
8	PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. 2022 ·Figshare ·Annalisa D’Avola, Nathalie Legrave, Mylène Tajan, Probir Chakravarty, (unknown), Hamish W. King, Katarína Kľučková, Eric C. Cheung, Andrew Clear, (unknown), Lingling Zhang, Louisa K. James, James I. MacRae, John G. Gribben, Dinis Pedro Calado, Karen H. Vousden, John C. Riches	25
9	Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics 2021 ·Science Immunology ·Hamish W. King, Nara Orban, John C. Riches, Andrew Clear, Gary Warnes, Sarah A. Teichmann, Louisa K. James	137
10	The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials 2021 ·Cancers ·(unknown), John C. Riches	23
11	Antibody Repertoire and Gene Expression Dynamics of Diverse Human B Cell States During Affinity Maturation 2020 ·SSRN Electronic Journal ·Hamish W. King, Nara Orban, John C. Riches, Andrew Clear, Gary Warnes, Sarah A. Teichmann, Louisa K. James	1
12	Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients breakdown → 2020 ·Blood ·Abi Vijenthira, Inna Y. Gong, Thomas A. Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, Fernando Martín‐Moro, Jérôme Razanamahery, John C. Riches, Jeffrey I. Zwicker, Rushad Patell, Marie Christiane Vekemans, Lydia Scarfò, Thomas Chatzikonstantinou, Halil Yıldız, (unknown), Ioannis Mantzaris, William A. Wood, Lisa K. Hicks	330
13	Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia 2016 ·Current Cancer Drug Targets ·John C. Riches, John G. Gribben	14
14	Understanding the Immunodeficiency in Chronic Lymphocytic Leukemia 2013 ·Hematology/Oncology Clinics of North America ·John C. Riches, John G. Gribben	75
15	Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy 2012 ·Current Pharmaceutical Design ·John C. Riches, Alan G. Ramsay, John G. Gribben	20
16	Immune Reconstitution in Chronic Lymphocytic Leukemia 2012 ·Current Hematologic Malignancy Reports ·John C. Riches, Alan G. Ramsay, John G. Gribben	23
17	Chronic Lymphocytic Leukemia: An Update on Biology and Treatment 2011 ·Current Oncology Reports ·John C. Riches, Alan G. Ramsay, John G. Gribben	13
18	T-cell function in chronic lymphocytic leukaemia 2010 ·Seminars in Cancer Biology ·John C. Riches, Alan G. Ramsay, John G. Gribben	42
19	Burkitt lymphoma following renal transplantation 2009 ·British Journal of Haematology ·John C. Riches, Kikkeri N. Naresh, Alistair Reid, Donald Macdonald	1
20	Preoperative Duplex on Admission Prevents Unnecessary Carotid Surgery 2004 ·European Journal of Vascular and Endovascular Surgery ·(unknown), John C. Riches, Linda Hands, Ashok Handa	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact